IP Library Granted Patent US 12,465,521
Granted Patent B2
US 12,465,521 · App. 18/303,105 · Granted Nov 11, 2025

Hybrid 2-port vitrectomy and combined treatment and infusion probe

Inventor: Paul R. Hallen (Colleyville, TX)
Assignee: Alcon Inc.
A61F9/008A61F2009/00874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,465,521
App. No.
18/303,105
Granted
Nov 11, 2025
Kind
B2
Abstract

The present disclosure generally relates to microsurgical instruments for ophthalmic surgical procedures, and more particularly, methods and microsurgical instruments for vitreoretinal procedures. In certain embodiments described herein, a vitreoretinal procedure is performed utilizing two surgical instruments: 1) a treatment instrument configured to a) treat a target ophthalmic tissue (e.g., sever and remove the vitreous body), and b) infuse fluid into the intraocular space to maintain intraocular pressure (IOP); and 2) an illumination probe for providing illumination within the intraocular space. The combined treatment and infusion functionalities of the treatment instrument eliminate the need for a separate infusion cannula, thus enabling the vitreoretinal procedure to be performed with only two instruments and reducing the number of incisions made in the eye. Additionally, utilization of two instruments facilitates easier manipulation of the eye by a surgeon, as one of the two instruments can be used to “steer” the eye during the procedure.

Claims (34)

1 . A surgical instrument for performing an ophthalmic surgical procedure, comprising:

a handpiece; and

a probe at a distal end of the handpiece configured to be inserted into an intraocular space of an eye, the probe comprising:

an infusion portion having a first diameter, the infusion portion comprising:

a port for directing fluid into a surgical site within the intraocular space; and

a channel fluidly coupled to the port for delivering the fluid to the port; and

a treatment portion distal to the infusion portion and having a second diameter smaller than the first diameter, the treatment portion comprising:

a device for treating a tissue at a surgical site, comprising:

a sealed laser probe having a tube with a window press fit into a distal end of the tube;

one or more optical fibers extending down a length of an interior of the sealed laser probe tube to deliver laser light and illumination light through the window and illumination light through a distal side wall of the sealed laser probe tube;

wherein the sealed laser probe tube comprises masking along a majority of a length of the laser probe tube except the distal side wall which comprises at least a ¼ of a length of the laser probe tube extending from the distal end of the sealed laser probe tube.

2 . The surgical instrument of claim 1 , wherein the device is a non-aspirating laser vitrectomy device.

3 . The surgical instrument of claim 1 , wherein the device is an elongated laser-propagating member for performing endophotocoaguation or laser ablation.

4 . The surgical instrument of claim 1 , wherein the infusion portion has a diameter of 23 gauge and the treatment portion has a diameter of 25 gauge.

5 . The surgical instrument of claim 1 , wherein the infusion portion has a diameter of 25 gauge and the treatment portion has a diameter of 27 gauge.

6 . The surgical instrument of claim 1 , wherein the infusion portion has a diameter of 27 gauge and the treatment portion has a diameter of 29 gauge.

7 . The surgical instrument of claim 1 , wherein a length of the infusion portion is about 50% to about 90% of a length of the probe.

8 . The surgical instrument of claim 1 , wherein a length of the infusion portion is about 50% to about 75% of the length of the probe.

9 . A system for performing an ophthalmic surgical procedure, comprising:

an endoillumination instrument; and

a treatment instrument for treating a tissue in an intraocular space of an eye, comprising:

a handpiece; and

a probe at a distal end of the handpiece configured to be inserted into the intraocular space of the eye, the probe comprising:

an infusion portion having a first diameter, the infusion portion comprising:

a port for directing fluid into a surgical site within the intraocular space; and

a channel fluidly coupled to the port for delivering the fluid to the port; and

a treatment portion distal to the infusion portion and having a second diameter smaller than the first diameter, the treatment portion comprising:

a device for treating a tissue at a surgical site, wherein at least one of the endoillumination instrument and the treatment instrument are configured to be manipulated by a surgeon to control a position of an eye during the ophthalmic surgical procedure;

wherein the device comprises:

a sealed laser probe having a tube with a window press fit into a distal end of the tube;

one or more optical fibers extending down a length of an interior of the sealed laser probe tube to deliver laser light and illumination light through the window and illumination light through a distal side wall of the sealed laser probe tube;

wherein the sealed laser probe tube comprises masking along a majority of a length of the laser probe tube except the distal side wall which comprises at least a ¼ of a length of the laser probe tube extending from the distal end of the sealed laser probe tube.

10 . The system of claim 9 , wherein the device is a non-aspirating laser vitrectomy device.

11 . The system of claim 9 , wherein the device is an elongated laser-propagating member for performing endophotocoaguation or laser ablation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2023
From: HALLEN, PAUL R.
To: ALCON VISION, LLC
Reel/Frame 063749/0979 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2023
From: ALCON VISION, LLC
To: ALCON INC.
Reel/Frame 063750/0001 →
Continuity (2)
Provisional Application 63363739 · Apr 28, 2022
Related Publication 20230346600A1 · Nov 2, 2023
References Cited (11)
US 4011869A · Seiler, Jr. · 1977 [cited by applicant]
US 5651783A · Raynard · 1997 [cited by applicant]
US 9956053B2 · Diao et al. · 2018 [cited by applicant]
US 10376414B2 · Hallen et al. · 2019 [cited by applicant]
US 20050245916A1 · Connor · 2005 [cited by examiner]
US 20080172078A1 · Svetic · 2008 [cited by examiner]
US 20100106054A1 · Hangai · 2010 [cited by examiner]
US 20130090635A1 · Mansour · 2013 [cited by examiner]
US 20170165114A1 · Hallen · 2017 [cited by examiner]
US 20170172796A1 · Biancalana et al. · 2017 [cited by applicant]
US 20210290438A1 · Hallen · 2021 [cited by applicant]